Drug Developer Accused Of Botching 401(k) Plan Management

Law360 (April 16, 2020, 2:26 PM EDT) -- A group of Pharmaceutical Product Development 401(k) plan participants have accused the drug development company of costing workers millions of dollars in retirement savings by saddling the plan with high-cost investment choices and not properly reviewing its investment lineup.

In a proposed class action filed in North Carolina federal court Wednesday, Pharmaceutical Product Development LLC Retirement Savings Plan participants Karl Kendall, Vincenzo Pernice and Suzanne Rainey claimed that PPD, its board of directors and a benefits administrative committee flouted the Employee Retirement Income Security Act.

Even though “the plan had at least half a billion in assets” from mid-April 2014, which...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!